Showing results (301-310 of 395) with videos related to
Sort By:
Pageof 40
Breast Cancer Research and Treatment|May 29, 2019
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trialMatteo Lambertini, Christine Campbell, Richard D Gelber, et al.Journal of the National Cancer Institute|November 2, 2006
Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assaysMeredith M Regan, Giuseppe Viale, Mauro G Mastropasqua, et al.Cancer|October 19, 2018
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trialsMatteo Lambertini, Samuel Martel, Christine Campbell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017
Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 StudySigne Borgquist, Anita Giobbie-Hurder, Thomas P Ahern, et al.International Journal of Radiation Oncology, Biology, Physics|March 15, 2018
Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 TrialYoussef H Zeidan, Joyce G Habib, Lieveke Ameye, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VIGünther Gruber, Marco Bonetti, M Laura Nasi, et al.Journal of the National Cancer Institute|March 4, 2025
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugatesLaura Pala, Federico Merlo, Isabella Sala, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2018
Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA StudyMartin Filipits, Urania Dafni, Michael Gnant, et al.Journal of the National Cancer Institute|January 31, 2008
Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancerGiuseppe Viale, Meredith M Regan, Mauro G Mastropasqua, et al.The New England Journal of Medicine|July 13, 2004
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemiaSteven E Lipshultz, Nader Rifai, Virginia M Dalton, et al.Pageof 40